{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:09:57Z","timestamp":1792156197588,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jid.2025.07.029","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:29:57Z","timestamp":1755822597000},"page":"699-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immune and Biological Changes during Treatment in Patients with Nonsegmental Vitiligo and their Relation to Repigmentation"],"prefix":"10.1016","volume":"146","author":[{"given":"Wouter","family":"Ouwerkerk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhya S.","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Chielie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie O.P.","family":"van Uden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Hillenbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swann","family":"Gaulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus B.","family":"Kjellerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Loesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Hanser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel W.","family":"Bekkenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Wolkerstorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-0721","authenticated-orcid":false,"given":"Rosalie M.","family":"Luiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.07.029_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib2","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1038\/sj.onc.1208560","article-title":"The fibroblast growth factor binding protein is a novel interaction partner of FGF-7, FGF-10 and FGF-22 and regulates FGF activity: implications for epithelial repair","volume":"24","author":"Beer","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2025.07.029_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.jid.2025.07.029_bib4","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/exd.13879","article-title":"Vitiligo as a skin memory disease: the need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells","volume":"28","author":"Boniface","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jid.2025.07.029_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines tissue-resident CD8+ T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2025.07.029_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/der2.168","article-title":"Biomarkers and clinical indicators of disease activity in vitiligo","volume":"3","author":"Delbaere","year":"2022","journal-title":"Dermatol Rev"},{"key":"10.1016\/j.jid.2025.07.029_bib8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-cells and CD4(+) \/CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo","volume":"26","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.07.029_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00403-021-02228-9","article-title":"Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome","volume":"314","author":"El-Domyati","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2025.07.029_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2025.07.029_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.abd.2021.04.014","article-title":"Fatty acid-binding protein 4 circulating levels in non-segmental vitiligo","volume":"97","author":"Farag","year":"2022","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jid.2025.07.029_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094772","article-title":"Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin","volume":"9","author":"Fujita","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2025.07.029_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2025.07.029_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1755-148X.2008.00505.x","article-title":"Novel MITF targets identified using a two-step DNA microarray strategy","volume":"21","author":"Hoek","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.07.029_bib16","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.1074\/jbc.M109.097907","article-title":"Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1","volume":"285","author":"Hui","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jid.2025.07.029_bib17","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"g:profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2025.07.029_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-012-2737-4","article-title":"Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?","volume":"56","author":"Kralisch","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jid.2025.07.029_bib19","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.3390\/ijms24055001","article-title":"Molecular mechanisms of neurogenic inflammation of the skin","volume":"24","author":"Marek-Jozefowicz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2025.07.029_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjd.19422","article-title":"What is successful repigmentation in vitiligo from the point of view of patients?","volume":"184","author":"Narayan","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib21","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3389\/fimmu.2018.01347","article-title":"Metabolic reprogramming and longevity of tissue-resident Memory T Cells","volume":"9","author":"Pan","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.07.029_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s41702-018-0030-y","article-title":"Exploring vitiligo susceptibility and management: a brief review","volume":"2","author":"Rahman","year":"2018","journal-title":"Biomed Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","article-title":"Innate immune mechanisms in vitiligo: danger from within","volume":"25","author":"Richmond","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jid.2025.07.029_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2016.11.010","article-title":"Current and emerging treatments for vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase","volume":"4","author":"Schallreuter","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jid.2025.07.029_bib26","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.3390\/jcm13175225","article-title":"Vitiligo: from pathogenesis to treatment","volume":"13","author":"Speeckaert","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jid.2025.07.029_bib27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.autrev.2017.07.005","article-title":"Biomarkers of disease activity in vitiligo: a systematic review","volume":"16","author":"Speeckaert","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2025.07.029_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40257-017-0298-5","article-title":"Vitiligo: an update on pathophysiology and treatment options","volume":"18","author":"Speeckaert","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","article-title":"Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity","volume":"76","author":"Strassner","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib30","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2025.07.029_bib31","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/exd.13535","article-title":"Regulatory T cells in autoimmune skin diseases","volume":"28","author":"Ujiie","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib32","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib33","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jid.2015.12.040","article-title":"Development and validation of the Vitiligo Extent Score (VES): an international collaborative initiative","volume":"136","author":"van Geel","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.07.029_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1755-148X.2011.00922.x","article-title":"In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial","volume":"25","author":"van Geel","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.07.029_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7150\/ijbs.17318","article-title":"Novel approaches to vitiligo treatment via modulation of mTOR and NF-\u03baB pathways in human skin melanocytes","volume":"13","author":"Wan","year":"2017","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jid.2025.07.029_bib36","first-page":"CD003263","article-title":"Interventions for vitiligo","volume":"2015","author":"Whitton","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jid.2025.07.029_bib37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/pcmr.12803","article-title":"Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanoma","volume":"32","author":"Willemsen","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.07.029_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdin.2025.07.005","article-title":"Variation in depression risk by race and ethnicity in vitiligo","author":"Yan","year":"2025","journal-title":"JAAD Int"},{"key":"10.1016\/j.jid.2025.07.029_bib39","article-title":"Vitiligo skin biomarkers associated with favorable therapeutic response","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.07.029_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051040","article-title":"Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2025.07.029_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7073472","article-title":"Protein regulator of cytokinesis 1 (PRC1) upregulation promotes immune suppression in liver hepatocellular carcinoma","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Immunol Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25023504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25023504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:31:56Z","timestamp":1779942716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25023504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0022202X25023504"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.07.029","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune and Biological Changes during Treatment in Patients with Nonsegmental Vitiligo and their Relation to Repigmentation","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}